Pheast

Developer of immunotherapeutics for cancer treatment

placePalo Alto, California, United States calendar_todayFounded 2020 groups20 employees language pheast.com

Social engagement

Social engagement: 5.6K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Catalio Capital Management, Arch Venture Partners, Alexandria, Stanford University Presidential Venture Fund.

Investor typeCountShare
Venture capital375%
Other / undisclosed125%

Recent activity

28 May 2026
Event
ASCO26
11 May 2026
Product launch
PHST677
1 May 2026
Event
PEGSummit data presentation on Pheast's novel approach to coupling tumor-specific payload delivery with a new target for immune engagement
Coming soon